Tags

Type your tag names separated by a space and hit enter

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    rsteinbrook@attglobal.net

    Source

    The New England journal of medicine 355:14 2006 Oct 05 pg 1409-12

    MeSH

    Angiogenesis Inhibitors
    Antibodies, Monoclonal
    Antibodies, Monoclonal, Humanized
    Bevacizumab
    Humans
    Injections
    Macular Degeneration
    Ranibizumab

    Pub Type(s)

    Comment
    Journal Article

    Language

    eng

    PubMed ID

    17021315

    Citation

    Steinbrook, Robert. "The Price of Sight--ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration." The New England Journal of Medicine, vol. 355, no. 14, 2006, pp. 1409-12.
    Steinbrook R. The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration. N Engl J Med. 2006;355(14):1409-12.
    Steinbrook, R. (2006). The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration. The New England Journal of Medicine, 355(14), pp. 1409-12.
    Steinbrook R. The Price of Sight--ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration. N Engl J Med. 2006 Oct 5;355(14):1409-12. PubMed PMID: 17021315.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration. A1 - Steinbrook,Robert, PY - 2006/10/6/pubmed PY - 2006/10/19/medline PY - 2006/10/6/entrez SP - 1409 EP - 12 JF - The New England journal of medicine JO - N. Engl. J. Med. VL - 355 IS - 14 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/17021315/The_price_of_sight__ranibizumab_bevacizumab_and_the_treatment_of_macular_degeneration_ L2 - http://www.nejm.org/doi/full/10.1056/NEJMp068185?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -